Results 91 to 100 of about 8,261 (192)

Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data

open access: yes, 2022
Background: This study was designed to investigate the effectiveness of CoronaVac in preventing COVID-19 in healthcare workers (HCWs) during the Alpha variant-dominant period. Materials & methods: Follow-up was initiated 14 days after the second dose for
Pehlivanoglu, Filiz   +5 more
core   +1 more source

Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study

open access: yesJournal of Hematology & Oncology, 2022
Background The World Health Organization has defined a list of adverse events of special interest (AESI) for safety surveillance of vaccines. AESI have not been adequately assessed following COVID-19 vaccination in patients with cancer contributing to ...
Wei Kang   +12 more
doaj   +1 more source

SARS‐CoV‐2 Spike Protein as a Target of the COVID‐19 Vaccine Disrupts Insulin Signaling in Type 2 Diabetes

open access: yesMedComm, Volume 6, Issue 11, November 2025.
SARS Cov‐2 spike protein disrupts insulin signaling in type 2 diabetes as a target of the COVID‐19 vaccine in subject with type 2 diabetes (T2D), while metformin improved the insulin signaling variations induced by mRNA COVID‐19 vaccine boosters in mice.
Lixiang Zhai   +12 more
wiley   +1 more source

Crude incidence rate of outcomes for CoronaVac or BNT162b2 recipients, COVID-19 patients, and respective matched controls, and HR of events for CoronaVac or BNT162b2 recipients and COVID-19 patients in comparison with their respective matched controls.

open access: yes, 2023
Crude incidence rate of outcomes for CoronaVac or BNT162b2 recipients, COVID-19 patients, and respective matched controls, and HR of events for CoronaVac or BNT162b2 recipients and COVID-19 patients in comparison with their respective matched controls.
Ivan Chi Ho Au (12902264)   +15 more
core   +1 more source

Should We Advance Our Understanding of Immunoglobulin E in Viral Immunity?

open access: yesImmunology, Volume 176, Issue 3, Page 312-321, November 2025.
Immunoglobulin E has been extensively studied in allergies and parasitic diseases. Antigen‐specific IgE has been identified as part of the humoral response to viruses. This revision speculates on possible functionalities for IgE, such as neutralisation, cytotoxicity and immunopathology of viral diseases, and provide insights about gaps to fill in ...
Amanda Izeli Portilho   +3 more
wiley   +1 more source

Crude incidence rate of outcomes for CoronaVac or BNT162b2 recipients, COVID-19 patients, and respective matched controls, and incidence rate ratio of events for CoronaVac or BNT162b2 recipients and COVID-19 patients in comparison with their respective matched controls.

open access: yes, 2023
Crude incidence rate of outcomes for CoronaVac or BNT162b2 recipients, COVID-19 patients, and respective matched controls, and incidence rate ratio of events for CoronaVac or BNT162b2 recipients and COVID-19 patients in comparison with their respective ...
Ivan Chi Ho Au (12902264)   +15 more
core   +1 more source

Humoral Immune Response to Breakthrough Infection With SARS‐CoV‐2 Delta and Omicron Variants

open access: yesiLABMED, Volume 3, Issue 3, Page 266-274, September 2025.
Patients with breakthrough infections of the Omicron variant exhibited significantly higher levels of neutralizing antibodies and IgG than those infected with the Delta variant. By contrast, Delta‐infected patients showed higher levels of IgM and IgA than Omicron‐infected patients.
Xihong Zhang   +12 more
wiley   +1 more source

Human T Cell Responses to Flavivirus Vaccines

open access: yesEuropean Journal of Immunology, Volume 55, Issue 8, August 2025.
This review summarises current knowledge of T cell responses induced by flavivirus vaccines being licensed or under development. Existing vaccines against flaviviruses have been developed and analysed primarily in the context of antibody responses, while the role of T cells in contributing to immunity against flaviviruses is less studied.
David Wullimann, Hans‐Gustaf Ljunggren
wiley   +1 more source

Crude incidence rate of outcomes for 2 doses of CoronaVac or BNT162b2 recipients and respective matched controls, and hazard ratio for 2 doses of CoronaVac or BNT162b2 recipients in comparison with their respective matched controls.

open access: yes, 2023
Crude incidence rate of outcomes for 2 doses of CoronaVac or BNT162b2 recipients and respective matched controls, and hazard ratio for 2 doses of CoronaVac or BNT162b2 recipients in comparison with their respective matched controls.
Ivan Chi Ho Au (12902264)   +15 more
core   +1 more source

Vaccination Coverage Against Coronavirus Disease 2019 in People Living on Quilombos in Brazil and Its Association With the Human Development Index and the Quality of the Health System

open access: yesJournal of Medical Virology, Volume 97, Issue 8, August 2025.
ABSTRACT Since the slavery period in Brazil, the Quilombola population has faced problems related to social vulnerability and poor health. The coronavirus disease (COVID)‐19 pandemic has made this social inequality more evident, and the postpandemic scenario has proved even more challenging with the difficult access to basic living conditions ...
Patrícia Teixeira Costa   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy